These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline. Bossuyt L; Bosschaert J; Richert B; Cromphaut P; Mitchell T; Al Abadie M; Henry I; Bewley A; Poyner T; Mann N; Czernielewski J Eur J Dermatol; 2003; 13(2):130-5. PubMed ID: 12695127 [TBL] [Abstract][Full Text] [Related]
24. [Cyclines and acne: pay attention to adverse drug reactions! A recent literature review]. Grasset L; Guy C; Ollagnier M Rev Med Interne; 2003 May; 24(5):305-16. PubMed ID: 12763176 [TBL] [Abstract][Full Text] [Related]
26. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
27. Tetracycline and other tetracycline-derivative staining of the teeth and oral cavity. Sánchez AR; Rogers RS; Sheridan PJ Int J Dermatol; 2004 Oct; 43(10):709-15. PubMed ID: 15485524 [TBL] [Abstract][Full Text] [Related]
30. [Lupus-like disease due to minocycline]. Marai I; Shoenfeld Y Harefuah; 2002 Feb; 141(2):151-2, 223, 222. PubMed ID: 11905086 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of tigecycline against isolates from patients enrolled in phase 3 clinical trials of treatment for complicated skin and skin-structure infections and complicated intra-abdominal infections. Bradford PA; Weaver-Sands DT; Petersen PJ Clin Infect Dis; 2005 Sep; 41 Suppl 5():S315-32. PubMed ID: 16080070 [TBL] [Abstract][Full Text] [Related]
32. [Doxycycline]. Bonnetblanc JM Ann Dermatol Venereol; 2002; 129(6-7):874-82. PubMed ID: 12218915 [TBL] [Abstract][Full Text] [Related]
33. Minocycline. Jonas M; Cunha BA Ther Drug Monit; 1982; 4(2):137-45. PubMed ID: 7048646 [TBL] [Abstract][Full Text] [Related]
34. Tigecycline: first of a new class of antimicrobial agents. Rose WE; Rybak MJ Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487 [TBL] [Abstract][Full Text] [Related]
35. Establishing the role of tigecycline in an era of antimicrobial resistance. Schafer JJ; Goff DA Expert Rev Anti Infect Ther; 2008 Oct; 6(5):557-67. PubMed ID: 18847395 [TBL] [Abstract][Full Text] [Related]
36. Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion. Hua R; Walz W Brain Res; 2006 May; 1090(1):172-81. PubMed ID: 16647693 [TBL] [Abstract][Full Text] [Related]
37. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases. Hertl M; Zillikens D; Borradori L; Bruckner-Tuderman L; Burckhard H; Eming R; Engert A; Goebeler M; Hofmann S; Hunzelmann N; Karlhofer F; Kautz O; Lippert U; Niedermeier A; Nitschke M; Pfütze M; Reiser M; Rose C; Schmidt E; Shimanovich I; Sticherling M; Wolff-Franke S J Dtsch Dermatol Ges; 2008 May; 6(5):366-73. PubMed ID: 18201220 [TBL] [Abstract][Full Text] [Related]
38. [Severe pruriginous acne in dialysed renal failure. Diagnostic difficulties and efficacy of isotretinoin]. Grange F; Mitschler A; Genestier S; Guillaume JC Ann Dermatol Venereol; 2001 Nov; 128(11):1215-9. PubMed ID: 11908165 [TBL] [Abstract][Full Text] [Related]
39. Neutrophilic dermatoses: a review of current treatment options. Cohen PR Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442 [TBL] [Abstract][Full Text] [Related]